MoonLake Immunotherapeutics
MLTX
#5912
Rank
C$1.41 B
Marketcap
C$20.04
Share price
-3.92%
Change (1 day)
-73.14%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2025 (TTM): -C$0.3 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$0.19 Billion a decrease over its 2023 earnings that were of -C$74.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.3 Billion63.15%
2024 -C$0.19 Billion142.55%
2023 -C$74.92 Million-16.81%
2022 -C$90.06 Million